Comparison of EQ-5D VAS valuations: analysis of background variables
Harri Sintonen(Fairfield Hospital), Frank de Charro(Erasmus University Rotterdam), Xavier Badía(Oblikue Consulting (Spain)), Jan J.V. Busschbach(Erasmus University Rotterdam), Montserrat Roset, S Oppe(Erasmus University Rotterdam), Martin Nieuwenhuizen(Erasmus University Rotterdam), Paul F. M. Krabbe(Radboud University Nijmegen), Wolfgang Greiner(Bielefeld University), Arto Öhinmaa(University of Alberta), Tom Weijnen(Erasmus University Rotterdam)
Cited by 12
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476
A single European currency for EQ-5D health states
|The European Journal of Health Economics|2003|465